Jyong Biotech Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-4.67	-3.02	-4.4	-6.63	-4.2
Depreciation & Amortization	0.1	0.12	0.13	0.12	0.12
Other Adjustments	-19.21	0.76	0.55	0.6	0.85
Changes in Accounts Payable	-0	0	-0	-0.03	0.01
Changes in Accrued Expenses	21.58	0.17	0.3	-0.18	0.27
Changes in Other Operating Activities	-0.84	-1.66	0.82	3.14	0.97
Operating Cash Flow	-3.04	-3.62	-2.6	-2.97	-1.98
Operating Cash Flow Growth	-	-	-	-	-
Capital Expenditures	-	-	-	-0.25	-0.14
Purchases of Investments	-16.87	-	-	-0.29	-1.83
Proceeds from Sale of Investments	16.87	-	0.1	1.93	0.66
Other Investing Activities	-13.51	-	-	-	-
Investing Cash Flow	-13.51	-	0.1	1.39	-1.31
Short-Term Debt Issued	23.1	9.24	9.8	11.34	5.62
Short-Term Debt Repaid	-22.94	-9.39	-9.11	-8.38	-5.57
Net Short-Term Debt Issued (Repaid)	0.16	-0.15	0.69	2.96	0.05
Long-Term Debt Issued	1.38	2.43	2.03	0.94	0.02
Long-Term Debt Repaid	-1.56	-0.07	-0.24	-0.29	-1.45
Net Long-Term Debt Issued (Repaid)	-0.18	2.36	1.78	0.65	-1.43
Issuance of Common Stock	17.77	-	-	-	-
Net Common Stock Issued (Repurchased)	17.77	-	-	-	-
Other Financing Activities	-0.11	-0.21	-0.45	-0.28	-
Financing Cash Flow	17.63	1.99	2.03	3.33	-1.38
Foreign Exchange Rate Adjustments	-0.01	-0.01	-0.05	-0.03	0.07
Net Cash Flow	1.08	-1.64	-0.53	1.72	-4.61
Free Cash Flow	-3.04	-3.62	-2.6	-3.22	-2.12
Free Cash Flow Growth	-	-	-	-	-
Free Cash Flow Per Share	-0.04	-0.05	-0.04	-0.04	-0.03
Levered Free Cash Flow	16.14	-2.18	-0.68	-0.21	-4.35
Unlevered Free Cash Flow	18.23	-3.42	-1.55	-0.02	-1.18

SEC Filings: 10-K · 10-Q